Nephrogenic systemic fibrosis: A clinicopathologic study of six cases

Journal of the American Academy of Dermatology

Volumn 57, Issue 1, 2007, Pages 105-111

  Pryor, Jennifer G ^a   Poggioli, George ^b   Galaria, Noreen ^b   Gust, Anthony ^b   Robison, John ^b   Samie, Faramarz ^b   Hanjani, N Michelle ^c   Scott, Glynis A ^b  

^a Departments of Pathology

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; GADOLINIUM;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MEDICAL RECORD REVIEW; NEPHROGENIC FIBROSING DERMOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE;

ADULT; AGED; CONTRAST MEDIA; ERYTHROPOIETIN; FEMALE; FIBROSIS; GADOLINIUM; HUMANS; KIDNEY FAILURE; MALE; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SKIN DISEASES; SURGICAL PROCEDURES, OPERATIVE;

EID: 34250201470     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2007.02.021     Document Type: Article

References (18)

1. Cowper S.E., Su L.D., Bhawan J., Robin H.S., and LeBoit P.E. Nephrogenic fibrosing dermopathy. Am J Dermatopathol 23 (2001) 383-393
2. Cowper S.E. Nephrogenic fibrosing dermopathy: the first 6 years. Curr Opin Rheumatol 15 (2003) 785-790
3. Cowper S.E., and Boyer P.J. Nephrogenic systemic fibrosis: an update. Curr Rheumatol Rep 8 (2006) 151-157
4. Mendoza F.A., Artlett C.M., Sandorfi N., Latinis K., Piera-Velazquez S., and Jimenez S.A. Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature. Semin Arthritis Rheum 35 (2006) 238-249
5. Jimenez S.A., Artlett C.M., Sandorfi N., Derk C., Latinis K., Sawaya H., et al. Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor beta1 expression in affected skin. Arthritis Rheum 50 (2004) 2660-2666
6. Cowper S.E., and Bucala R. Nephrogenic fibrosing dermopathy: suspect identified, motive unclear. Am J Dermatopathol 25 (2003) 358
7. Quan T.E., Cowper S., Wu S.P., Bockenstedt L.K., and Bucala R. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 36 (2004) 598-606
8. Cowper S.E., Bucala R., and Leboit P.E. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis-setting the record straight. Semin Arthritis Rheum 35 (2006) 208-210
9. Grobner T. Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?. Nephrol Dial Transplant 21 (2006) 1104-1108
10. Marckmann P., Skov L., Rossen K., Dupont A., Damholt M.B., Heaf J.G., et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 17 (2006) 2359-2362
11. Joffe P., Thomsen H.S., and Meusel M. Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis. Acad Radiol 5 (1998) 491-502
12. GE Healthcare. Omniscan Safety Update. June 6, 2006. Available at: http://www.amershamhealth-us.com/omniscan/safety/index.html. Accessed October 30, 2006.
13. US Food and Drug Administration. Public Health Advisory. June 8, 2006. Available at: http://www.fda.gov/cder/drug/advisory/gadolinium_agents.htm. Accessed October 30, 2006.
14. Swaminathan S., Ahmed I., McCarthy J.T., Albright R.C., Pittelkow M.R., Caplice N.M., et al. Nephrogenic fibrosing dermopathy and high-dose erythropoietin therapy. Ann Intern Med 145 (2006) 234-235
15. Haroon Z.A., Amin K., Jiang X., and Arcasoy M.O. A novel role for erythropoietin during fibrin-induced wound-healing response. Am J Pathol 163 (2003) 993-1000
16. Maloo M., Abt P., Kashyap R., Younan D., Zand M., Orloff M., et al. Nephrogenic systemic fibrosis among liver transplant recipients: a single institution experience and topic update. Am J Transplant 6 (2006) 2212-2217
17. Boyd A.S., Zic J.A., and Abraham J.L. Gadolinium deposition in nephrogenic fibrosing dermopathy. J Am Acad Dermatol 56 (2007) 27-30
18. High W.A., Ayers R.A., Chandler J., Zito G., and Cowper S.E. Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 56 (2007) 21-26